Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × ruxolitinib × Clear all

NCT02955940 2025-12-17

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

Phase 2 Active not recruiting

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT01423604 2018-02-12

RECAP

Phase 2 Completed

136 enrolled 19 charts

Gastrointestinal

Pancreatic Neoplasms